Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Hallberg

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
Journal of Medicinal Chemistry|March 16, 2007
Synthesis of a new class of druglike angiotensin II C-terminal mimics with affinity for the AT2 receptorJennie Georgsson, Christian Sköld, Milad Botros, et al.
Journal of Medicinal Chemistry|November 5, 2010
Disulfide cyclized tripeptide analogues of angiotensin IV as potent and selective inhibitors of insulin-regulated aminopeptidase (IRAP)Hanna Andersson, Heidi Demaegdt, Georges Vauquelin, et al.
Bioorganic & Medicinal Chemistry|October 11, 2005
Exploration of acyl sulfonamides as carboxylic acid replacements in protease inhibitors of the hepatitis C virus full-length NS3Robert Rönn, Yogesh A Sabnis, Thomas Gossas, et al.
Journal of Medicinal Chemistry|December 3, 2002
Relationships between structure and interaction kinetics for HIV-1 protease inhibitorsPer-Olof Markgren, Wesley Schaal, Markku Hämäläinen, et al.
Bioorganic & Medicinal Chemistry|March 5, 2003
Design and synthesis of HIV-1 protease inhibitors. Novel tetrahydrofuran P2/P2'-groups interacting with Asp29/30 of the HIV-1 protease. Determination of binding from X-ray crystal structure of inhibitor protease complexKarin Oscarsson, Martina Lahmann, Jimmy Lindberg, et al.
Bioorganic & Medicinal Chemistry|February 4, 2010
Discovery of potent BACE-1 inhibitors containing a new hydroxyethylene (HE) scaffold: exploration of P1' alkoxy residues and an aminoethylene (AE) central coreCatarina Björklund, Hans Adolfsson, Katarina Jansson, et al.
Chemistryopen|May 9, 2014
N-Aryl Isoleucine Derivatives as Angiotensin II AT2 Receptor LigandsMalte Behrends, Charlotta Wallinder, Anna Wieckowska, et al.
Bioorganic & Medicinal Chemistry|August 2, 2005
Synthesis, biological evaluation, and modeling studies of inhibitors aimed at the malarial proteases plasmepsins I and IIDaniel Muthas, Daniel Nöteberg, Yogesh A Sabnis, et al.
Journal of Medicinal Chemistry|October 29, 2013
Design and synthesis of P1-P3 macrocyclic tertiary-alcohol-comprising HIV-1 protease inhibitorsAdvait Joshi, Jean-Baptiste Véron, Johan Unge, et al.
Bioorganic & Medicinal Chemistry|November 5, 2002
Tetrapeptides as potent protease inhibitors of Hepatitis C Virus full-length NS3 (protease-helicase/NTPase)Anja Johansson, Anton Poliakov, Eva Akerblom, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
Journal of Medicinal Chemistry|March 16, 2007
Synthesis of a new class of druglike angiotensin II C-terminal mimics with affinity for the AT2 receptorJennie Georgsson, Christian Sköld, Milad Botros, et al.
Journal of Medicinal Chemistry|November 5, 2010
Disulfide cyclized tripeptide analogues of angiotensin IV as potent and selective inhibitors of insulin-regulated aminopeptidase (IRAP)Hanna Andersson, Heidi Demaegdt, Georges Vauquelin, et al.
Bioorganic & Medicinal Chemistry|October 11, 2005
Exploration of acyl sulfonamides as carboxylic acid replacements in protease inhibitors of the hepatitis C virus full-length NS3Robert Rönn, Yogesh A Sabnis, Thomas Gossas, et al.
Journal of Medicinal Chemistry|December 3, 2002
Relationships between structure and interaction kinetics for HIV-1 protease inhibitorsPer-Olof Markgren, Wesley Schaal, Markku Hämäläinen, et al.
Bioorganic & Medicinal Chemistry|March 5, 2003
Design and synthesis of HIV-1 protease inhibitors. Novel tetrahydrofuran P2/P2'-groups interacting with Asp29/30 of the HIV-1 protease. Determination of binding from X-ray crystal structure of inhibitor protease complexKarin Oscarsson, Martina Lahmann, Jimmy Lindberg, et al.
Bioorganic & Medicinal Chemistry|February 4, 2010
Discovery of potent BACE-1 inhibitors containing a new hydroxyethylene (HE) scaffold: exploration of P1' alkoxy residues and an aminoethylene (AE) central coreCatarina Björklund, Hans Adolfsson, Katarina Jansson, et al.
Chemistryopen|May 9, 2014
N-Aryl Isoleucine Derivatives as Angiotensin II AT2 Receptor LigandsMalte Behrends, Charlotta Wallinder, Anna Wieckowska, et al.
Bioorganic & Medicinal Chemistry|August 2, 2005
Synthesis, biological evaluation, and modeling studies of inhibitors aimed at the malarial proteases plasmepsins I and IIDaniel Muthas, Daniel Nöteberg, Yogesh A Sabnis, et al.
Journal of Medicinal Chemistry|October 29, 2013
Design and synthesis of P1-P3 macrocyclic tertiary-alcohol-comprising HIV-1 protease inhibitorsAdvait Joshi, Jean-Baptiste Véron, Johan Unge, et al.
Bioorganic & Medicinal Chemistry|November 5, 2002
Tetrapeptides as potent protease inhibitors of Hepatitis C Virus full-length NS3 (protease-helicase/NTPase)Anja Johansson, Anton Poliakov, Eva Akerblom, et al.
Pageof 11